Benessere Capital Acquisition Corp

Benessere Capital Acquisition Corp

  • Price (USD)10.37
  • Today's Change0.00 / 0.00%
  • Shares traded6.75k
  • 1 Year change+3.18%
  • Beta--
Data delayed at least 15 minutes, as of Sep 27 2022 21:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Benessere Capital Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company have not selected any specific business combination target and may pursue an initial business combination target in any business or industry. The Company intends to focus its search on technology-focused middle market and emerging growth companies in North, Central and South America.

  • Revenue in USD (TTM)0.00
  • Net income in USD-114.40k
  • Incorporated2020
  • Employees--
  • Location
    Benessere Capital Acquisition Corp777 Sw 37Th Avenue, Suite 510MIAMI 33135-3250United StatesUSA
  • Phone+1 (561) 467-5200
  • Fax+1 (302) 636-5454
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BENE:NAQ since
eCombustible Energy LLCAnnounced24 Nov 202124 Nov 2021Announced1.97%804.00m
Data delayed at least 15 minutes, as of Sep 27 2022 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Fat Projects Acquisition Corp0.00-461.49k140.62m----1.29-----0.0319-0.03190.007.710.00-------0.7953---0.7975--------------0.0002--------------
Credit Suisse Asset Management In FndInc13.82m-23.15m140.79m6.00--0.9626--10.19-0.4424-0.44240.26392.790.0589--3.03---9.865.57-10.335.8287.2686.61-167.5784.97--0.33560.3093103.45-13.79-0.302339.55-11.71--0.4505
Benessere Capital Acquisition Corp0.00-114.40k142.31m----1.47-----0.0076-0.00760.007.050.00-------0.1019---0.1042--------------0.0209------5,408.10------
Integral Acquisition 1 Corp0.00-1.83m142.46m----1.30-----0.1272-0.12720.007.630.00-------3.10---3.10--------------0.00--------------
Adara Acquisition Corp0.003.18m142.89m--44.971.26----0.2210.2210.007.910.00------2.72--2.73--------------0.0029------59,300.91------
Abrdn Global Infrastructure Income Fund18.07m22.41m143.36m--6.400.6988--7.932.532.532.0423.170.0903------11.20--11.22--81.94--124.00------0.00--1,859.32--821.36------
TG Venture Acquisition Corp0.00-1.45m143.60m----1.22-----0.2857-0.28570.008.160.00-------2.44---2.45--------------0.00--------------
Winvest Acquisition Corp0.00-676.79k143.75m----1.27-----0.0471-0.04710.007.850.00-------1.15---1.16--------------0.00--------------
Rf Acquisition Corp-100.00bn-100.00bn144.58m----1.24----------7.99----------------------------0.00--------------
LAVA Medtech Acquisition Corp0.0020.84m144.61m--6.941.27----1.451.450.007.950.00------34.77--34.87--------------0.00--------------
Integrated Wellness Acquisition Corp-100.00bn-100.00bn145.04m----1.27----------7.97----------------------------0.00--------------
Fintech Ecosystem Development Corp0.00291.74k145.05m0.00497.281.32176.90--0.02020.02020.007.600.00------0.5004--0.5014--------------0.00--------------
Gesher I Acquisition Corp0.00-2.39m145.31m----1.31-----0.1658-0.16580.007.600.00-------4.09---4.17--------------0.0091--------------
Nuveen Arizona Premium Income Mun Fd-100.00bn-100.00bn145.45m--------------------------------------------------------------
Monterey Bio Acquisition Corp0.00-1.13m145.45m----1.25-----0.0786-0.07860.008.110.00-------1.93---1.94--------------0.00-------58,223.00------
Oxbridge Acquisition Corp0.00-675.29k145.48m0.00--1.33-----0.0466-0.04660.007.530.00-------1.15---1.15-------------0.45790.00--------------
Data as of Sep 27 2022. Currency figures normalised to Benessere Capital Acquisition Corp's reporting currency: US Dollar USD

Institutional shareholders

54.43%Per cent of shares held by top holders
HolderShares% Held
Glazer Capital LLCas of 30 Jun 20221.23m11.44%
Mizuho Securities USA LLCas of 30 Jun 2022750.61k7.00%
Highbridge Capital Management LLCas of 31 Jul 2022737.13k6.87%
Meteora Capital LLCas of 30 Jun 2022688.30k6.42%
RPO LLCas of 30 Jun 2022511.63k4.77%
Cowen & Co. LLCas of 30 Jun 2022500.00k4.66%
W.R. Berkley Corp. (Investment Portfolio)as of 30 Jun 2022478.53k4.46%
Shaolin Capital Management LLCas of 30 Jun 2022424.27k3.96%
First Trust Capital Management LPas of 30 Jun 2022319.68k2.98%
Cohanzick Management LLCas of 30 Jun 2022200.00k1.87%
More ▼
Data from 30 Jun 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.